MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

“Patient safety is paramount, and we’re pleased with this important step forward by the FDA, which allows us to continue expanding enrollment in this first-of-its-kind study,” said Adnan Siddiqui, MD, ...
GlobalData on MSN

Rocket points to Danon gene therapy’s safety after Phase II protocol change

Three patients with the rare lysosome-linked disease have safely received RP-A501, with no cases of capillary leak syndrome observed thus far.

Priovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS)

CS is a highly morbid, chronic, and disfiguring condition with no approved therapiesBrepocitinib is the first investigational therapy to generate ...

uniQure moves toward accelerated FDA approval for AMT-130

Qure ( (QURE)) has issued an update. On June 17, 2026, uniQure announced that the U.S. FDA has agreed the three-year analysis from its Phase I/II trial of AMT-130 in Huntington’s disease can serve as ...

NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the ...

SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...